FONAR CORPORATION PRESS RELEASE NEWS Fonar Corporation For Immediate Release The Inventor of MR Scanning Contact: Daniel Culver An ISO 9001 Company Director of Communications Melville, New York 11747 E-mail: investor@fon

Announces Fiscal 2018 2nd Quarter and Six Months Financial Results

26% Increase in Income from Operations, to $5.8 million, for the quarter ended December 31, 2017, versus same quarter during prior

10% Increase in Total Revenues - Net, to $20.2 million, for the quarter ended December 31, 2017, versus same quarter during

3% Decrease in Diluted Net Income per Common Share available to Common Shareholders to $0.61, for the quarter ended December 31,

2017, versus same quarter during prior year.

6% Increase in Net Income, to $5.2 million, for the quarter ended December 31, 2017, versus same quarter during prior year.

NEW YORK, February 12, 2018 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning , reported today its financial

results for the 2nd Fiscal Quarter of 2018 and the six month period ended December 31, 2017. The

Company's two industry segments are: development, manufacturing and servicing of the FONAR UPRIGHT Multi-Position

MRI, aka Stand-Up MRI, and management of 26 MRI centers through its subsidiary,

Health Management Company of America (HMCA).

FONAR UPRIGHT Multi-Position MRI scanner is the world's only MRI scanner licensed under FONAR's multiple

UPRIGHT MRI patents to scan all the patient's body parts in their normal full weight-bearing UPRIGHT position.

FONAR's substantial list of patents includes recent patents for its technology enabling full weight-bearing MRI imaging

on all the gravity sensitive regions of the human anatomy, especially the brain, extremities, spine and cerebrospinal fluid (CSF)

Revenues - Net, for the quarter ended December 31, 2017 increased 10% to $20.2 million as compared to the quarter ended

December 31, 2016, of $18.4 million.

Revenues - Net, for the six month period ended December 31, 2017, increased 6% to $39.5 million as compared to the six month

period ended December 31, 2016, of $37.1 million.

from Operations, for the quarter ended December 31, 2017, increased 26% to $5.8 million, as compared to the quarter ended December

31, 2016, of $4.6 million.

from Operations, for the six month period ended December 31, 2017, increased 13% to $10.6 million as compared to the six month

period ended December 31, 2016, of $9.4 million.

Income, for the quarter ended December 31, 2017, increased 6% to $5.2 million, as compared to the quarter ended December 31, 2016,

Income, for the six month period ended December 31, 2017, increased 4% to $9.8 million, as compared to the six month period ended

December 31, 2016, of $9.4 million.

Income Available to Common Stockholders, for the quarter ended December 31, 2017, decreased 1% to $3.9 million as compared to

the quarter ended December 31, 2016, of $4.0 million.

Income Available to Common Stockholders, for the six month period ended December 31, 2017, increased 1% to $7.4 million, as compared

to the six month period ended December 31, 2016, of $7.3 million.

CORPORATION AND SUBSIDIARIES

Net Income per Common Share Available to Common Stockholders, for the quarter ended December 31, 2017, decreased 3% to $0.62 per

share, as compared to the quarter ended December 31, 2016, of $0.64 per share.

Net Income per Common Share Available to Common Stockholders, for the six month period ended December 31, 2017, decreased 1% to

$1.18 per share, as compared to the quarter ended December 31, 2016, of $1.19 per share.

Net Income per Common Share Available to Common Stockholders, for the quarter ended December 31, 2017, decreased 3% to $0.61 per

share, as compared to the quarter ended December 31, 2016, of $0.63 per share.

Net Income per Common Share Available to Common Stockholders, for the six month period ended December 31, 2017, decreased 1% to

$1.16 per share, as compared to the quarter ended December 31, 2016, of $1.17 per share.

Assets, at December 31, 2017, was $105.2 million, as compared to $98.8 million at June 30, 2017.

Current Assets, at December 31, 2017, was $60.2 million, as compared to $53.4 million at June 30, 2016.

Cash and Cash Equivalents, at December 31, 2017, was $14.2 million, as compared to $10.1 million at June 30, 2017.

Liabilities, at December 31, 2017, was $15.2 million, as compared to $15.9 million at June 30, 2017.

Current Liabilities, at December 31, 2017, was $13.6 million, as compared to $14.2 million at June 30, 2017.

Tax Cuts and Jobs Act was signed into law on December 22, 2017 and makes numerous changes to the Internal Revenue Code.

Among other changes, the Act reduces the US corporate income tax rate to 21% effective January 1, 2018. Because the Act

became effective mid-way through the Company's tax year, the Company will have a US statutory income tax rate of 27.7% for

the fiscal 2018 and will have a 21% statutory income tax rate for fiscal years thereafter.

ASC Topic 740, Accounting for Income Taxes, the enactment of the Tax Act also requires companies to recognize the effects of changes

in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period

in which the new legislation in enacted. The Company's gross deferred tax assets and liabilities will be revalued from 35%

to 21% with a corresponding offset to the valuation allowance and any potential other taxes arising due to the Tax Act will result

in reductions to its net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act

to assess the full effects on its financial results, including disclosures, for our fiscal year ending June 30, 2018.

and CEO, Timothy R. Damadian said, "We are very pleased with the Company's second-quarter results. In fact, our income

from operations was close to the highest that we have ever achieved. Also, without the reduction in the deferred tax asset, we

would have had a year-over-year increase of 11% to $0.70 in Diluted Net Income per Common Share.

are already seeing the positive effects the recent federal tax cuts are having on the economy," Mr. Damadian continued.

"Higher wages and more jobs mean more Americans will be able to afford high-quality healthcare, which translates to increased

patient volume at HMCA-managed MRI scanning centers."

CORPORATION AND SUBSIDIARIES

rewarding to me," said Raymond V. Damadian, M.D., Chairman of the Board of Directors of FONAR Corporation, "how consistently

profitable we are. Our UPRIGHT Multi-Position (aka Stand-Up ) MRI scanner, for example, is unique. Its ability

to medically visualize the spine of a patient with back pain (which condition is responsible for a very significant percentage

of all MRI scans performed by all MRI scanners worldwide each year) in its normal upright position is unique. Its power to visualize

the spine supporting the full weight load that it normally has to sustain each day and to position the patient in the exact position

(that he/she specifies to the MRI technologist who is positioning him/her in the FONAR UPRIGHT Multi-Position MRI)

that generates his/her pain (which the conventional recumbent MRI cannot do) is unparalleled."

power of the FONAR UPRIGHT Multi-Position MRI to completely visualize ALL the anatomy components under their full

weight load that are giving rise to the patient's pain, which the conventional recumbent MRI cannot do, assures that the surgical

procedure chosen for his/her treatment will achieve the optimum outcome for the patient."

addition," continued Dr. Damadian, "I am very proud of the fact that it has been 7 years since FONAR has had a quarterly

loss. This is something we have all worked very hard to achieve."

The Inventor of MR Scanning , is located in Melville, NY, was incorporated in 1978,

and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world's first commercial

MRI in 1980, and went public in 1981. FONAR's signature product is the FONAR UPRIGHT Multi-Position MRI (also

known as the Stand-Up MRI), the only whole-body MRI that performs Position Imaging (pMRI ) and scans patients

in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position.

The FONAR UPRIGHT MRI often detects patient problems that other MRI scanners cannot because

they are lie-down and "weightless" only scanners. The patient-friendly UPRIGHT MRI has a near-zero patient claustrophobic

rejection rate. As a FONAR customer states, "If the patient is claustrophobic in this scanner, they'll be claustrophobic

in my parking lot." Approximately 85% of patients are scanned sitting while watching TV.

has new works-in-progress technology for visualizing and quantifying the cerebral hydraulics of the

central nervous system, the flow of cerebrospinal fluid (CSF), which circulates throughout the brain and vertebral column

at the rate of 32 quarts per day. This imaging and quantifying of the dynamics of this vital life-sustaining physiology of the

body's neurologic system has been made possible first by FONAR's introduction of the MRI and now by this latest works-in-progress

method for quantifying CSF in all the normal positions of the body, particularly in its upright flow against gravity. Patients

with whiplash or other neck injuries are among those who will benefit from this new understanding.

substantial list of patents includes recent patents for its technology enabling full weight-bearing MRI imaging of all the gravity

sensitive regions of the human anatomy, especially the brain, extremities and spine. It includes its newest technology for measuring

the Upright cerebral hydraulics of the central nervous system. FONAR's UPRIGHT Multi-Position MRI is the only

scanner licensed under these patents.

STAND-UP are registered trademarks and The Inventor of MR

Scanning , Full Range of Motion , Multi-Position , Upright Radiology ,

The Proof is in the Picture , True Flow , pMRI ,

Spondylography , Dynamic , Spondylometry , CSP ,

and Landscape , are trademarks of FONAR Corporation.

release may include forward-looking statements from the company that may or may not materialize. Additional information on factors

that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange